What technical signals does Immunovant (IMVT) have?

Immunovant current technical signals: no active technical signal.

Is Immunovant a cup-and-handle pattern?

No. Immunovant has no valid Cup signal right now.

What published figures are available for Immunovant?

Market cap: $6.81B. Trailing 12 months PER: -12.8×. Latest quarter PBR: 9.40×. Dividend yield: 0.00%.

← Signal Board

Immunovant stock price

이뮤노반트NASDAQ:IMVT · Nasdaq · Healthcare

$33.62-0.09%

2026-10-02 close

Today's signals · No active technical signal.

Signal details →

Immunovant last closed at $33.62 (-0.09%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -12.8×. Its overall grade ranks 187 of 739 stocks in Healthcare.

About this company

Immunovant last closed at $33.62 (-0.09%) on 2026-10-02. Listed on Nasdaq.

Details →

Reported results

Details →

Position in sector

Healthcare · Overall A- · 187/739

Valuation grade B

Details →

Related stocks

ArgenxCompetitor
FcRn 계열 자가면역질환 치료제 개발 경쟁사
UCBCompetitor
중증 자가면역·신경계 질환 치료제 시장에서 경쟁
Johnson & JohnsonCompetitor
자가면역·면역질환 치료제 포트폴리오를 보유한 대형 경쟁사

Details →

About Immunovant

What technical signals does Immunovant (IMVT) have?: Immunovant current technical signals: no active technical signal.
Is Immunovant a cup-and-handle pattern?: No. Immunovant has no valid Cup signal right now.
What published figures are available for Immunovant?: Market cap: $6.81B. Trailing 12 months PER: -12.8×. Latest quarter PBR: 9.40×. Dividend yield: 0.00%.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Turn what you saw on this name into a strategy

Ask Q about Immunovant, or open the plan table on the main site.

Ask Q ↗See plans ↗

From the names you found, through to a scheduled run

Set the conditions and they run at the scheduled time (live orders are not open yet).

See plans ↗

Quantus Signal · live data · not investment advice · Privacy Policy